Literature DB >> 26643987

The roles of serum alkaline and bone alkaline phosphatase levels in predicting heterotopic ossification following spinal cord injury.

M Citak1, D Grasmücke1, E M Suero2, O Cruciger3, R Meindl1, T A Schildhauer3, M Aach1.   

Abstract

STUDY
DESIGN: Retrospective chart review.
OBJECTIVES: To analyze the usefulness of serum alkaline phosphatase (AP) and bone alkaline phosphatase (BAP), as well as C-reactive protein (CRP) levels in predicting heterotopic ossification (HO).
SETTING: Department of Spinal Cord Injury and Department of General and Trauma Surgery, BG-University Hospital Bergmannsheil, Ruhr University Bochum, Germany.
METHODS: Between January 2003 and December 2013, 87 patients with HO around the hips met the inclusion criteria and were included in the study. Alkaline phosphatase, CRP and BAP were assessed and interpreted at the time of HO diagnosis and after radiation therapy in all patients.
RESULTS: At the time of HO diagnosis, 49 out of 87 patients (49.4%) had elevated alkaline phosphatase levels and 39 out of 87 patients (44.8%) had elevated BAP levels. Elevated CRP values were found in 67 patients (77.0%). Within 3 days after single-dose radiation therapy, elevated AP levels persisted in 38 patients (43.7%) and elevated BAP levels in 28 patients (32.2%).
CONCLUSIONS: The results obtained show that the determination of CRP, AP and BAP levels may not be considered a reliable screening method for early HO detection, subsequent to spinal cord injury.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26643987     DOI: 10.1038/sc.2015.211

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  15 in total

1.  Prostaglandin E2 measurements: their value in the early diagnosis of heterotopic ossification in spinal cord injury patients.

Authors:  B Schurch; M Capaul; M B Vallotton; A B Rossier
Journal:  Arch Phys Med Rehabil       Date:  1997-07       Impact factor: 3.966

2.  International Standards for Neurological and Functional Classification of Spinal Cord Injury. American Spinal Injury Association.

Authors:  F M Maynard; M B Bracken; G Creasey; J F Ditunno; W H Donovan; T B Ducker; S L Garber; R J Marino; S L Stover; C H Tator; R L Waters; J E Wilberger; W Young
Journal:  Spinal Cord       Date:  1997-05       Impact factor: 2.772

3.  Heterotopic bone formation: clinical, laboratory, and imaging correlation.

Authors:  J A Orzel; T G Rudd
Journal:  J Nucl Med       Date:  1985-02       Impact factor: 10.057

4.  Use of bone alkaline phosphatase to monitor alendronate therapy in individual postmenopausal osteoporotic women.

Authors:  B C Kress; I A Mizrahi; K W Armour; R Marcus; R D Emkey; A C Santora
Journal:  Clin Chem       Date:  1999-07       Impact factor: 8.327

5.  Risk factors for heterotopic ossification in patients with spinal cord injury: a case-control study of 264 patients.

Authors:  Mustafa Citak; Eduardo M Suero; Manuel Backhaus; Mirko Aach; Holger Godry; Renate Meindl; Thomas A Schildhauer
Journal:  Spine (Phila Pa 1976)       Date:  2012-11-01       Impact factor: 3.468

6.  C-reactive protein and erythrocyte sedimentation rate in patients with heterotopic ossification after spinal cord injury.

Authors:  Irene M Estrores; Amanda Harrington; Kresimir Banovac
Journal:  J Spinal Cord Med       Date:  2004       Impact factor: 1.985

7.  Heterotopic ossification after spinal cord injury. Epidemiology and risk factors.

Authors:  R H Wittenberg; U Peschke; U Bötel
Journal:  J Bone Joint Surg Br       Date:  1992-03

8.  Heterotopic ossification and HLA antigens.

Authors:  D E Garland; B Alday; K G Venos
Journal:  Arch Phys Med Rehabil       Date:  1984-09       Impact factor: 3.966

9.  The predictive value of creatine phosphokinase and alkaline phosphatase in identification of heterotopic ossification in patients after spinal cord injury.

Authors:  Rajendra S Singh; Michael C Craig; Charles R Katholi; Amie B Jackson; James M Mountz
Journal:  Arch Phys Med Rehabil       Date:  2003-11       Impact factor: 3.966

10.  The value of serum creatine kinase in early diagnosis of heterotopic ossification.

Authors:  Andrew L Sherman; Joan Williams; Lornette Patrick; Kresimir Banovac
Journal:  J Spinal Cord Med       Date:  2003       Impact factor: 1.985

View more
  6 in total

1.  The sensitivity of ultrasound screening examination in detecting heterotopic ossification following spinal cord injury.

Authors:  T Rosteius; E M Suero; D Grasmücke; M Aach; A Gisevius; M Ohlmeier; R Meindl; T A Schildhauer; M Citak
Journal:  Spinal Cord       Date:  2016-06-28       Impact factor: 2.772

2.  Evaluation of Salivary Cytokines for Diagnosis of both Trauma-Induced and Genetic Heterotopic Ossification.

Authors:  Hsiao Hsin Sung Hsieh; Michael T Chung; Ronald M Allen; Kavitha Ranganathan; Joe Habbouche; David Cholok; Jonathan Butts; Arminder Kaura; Ramkumar Tiruvannamalai-Annamalai; Chris Breuler; Caitlin Priest; Shawn J Loder; John Li; Shuli Li; Jan Stegemann; Steven L Kunkel; Benjamin Levi
Journal:  Front Endocrinol (Lausanne)       Date:  2017-04-24       Impact factor: 5.555

3.  Midterm Outcomes After Open Arthrolysis for Posttraumatic Elbow Stiffness in Children and Adolescents.

Authors:  Ji-Hao Ruan; Hao-Min Cui; Zi-Yang Sun; Shuai Chen; Wei Wang; Cun-Yi Fan
Journal:  J Pediatr Orthop       Date:  2021-03-01       Impact factor: 2.537

Review 4.  Heterotopic Ossification After Arthroscopic Procedures: A Scoping Review of the Literature.

Authors:  Liang Zhou; Shawn M Gee; Joshua A Hansen; Matthew A Posner
Journal:  Orthop J Sports Med       Date:  2022-01-18

Review 5.  The Survey of Cells Responsible for Heterotopic Ossification Development in Skeletal Muscles-Human and Mouse Models.

Authors:  Łukasz Pulik; Bartosz Mierzejewski; Maria A Ciemerych; Edyta Brzóska; Paweł Łęgosz
Journal:  Cells       Date:  2020-05-26       Impact factor: 6.600

6.  Ultrasonography Monitoring of Trauma-Induced Heterotopic Ossification: Guidance for Rehabilitation Procedures.

Authors:  Qing Wang; Peizhen Zhang; Pengdong Li; Xiangfen Song; Huijing Hu; Xuan Li; Wufan Chen; Xiaoyun Wang
Journal:  Front Neurol       Date:  2018-09-13       Impact factor: 4.003

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.